Testing effectiveness (Phase 2)Ended earlyNCT01783522
What this trial is testing
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Who this might be right for
Chemotherapeutic Agent ToxicityMultiple MyelomaPeripheral Neuropathy
Beth Faiman 9